15Jul 2025

UGI USER
Alzheimer’s disease Brain health Diabetes medications GLP-1 GLP-1 agonists medical research neurodegenerative diseases Obesity Therapeutic approach Weight loss drugs
55
0

GLP-1 Drugs: From Weight Loss to Alzheimer’s Care

GLP-1 Drugs Evolve from Obesity to Alzheimer’s: A Promising Therapeutic Approach Why in the News ? GLP-1-based drugs, initially developed for diabetes and later effective in obesity, are now being explored as a potential therapeutic intervention for Alzheimer’s disease and other neurodegenerative diseases. Research suggests GLP-1 may reduce brain inflammation and improve cognitive function, offering …

26Jun 2025

UGI USER
Alzheimer’s disease Alzheimer’s research Brain health dementia treatment genetic breakthrough inflammation control neurodegenerative diseases rare gene variant
51
0

Rare Gene Variant Fights Alzheimer’s via Inflammation

RARE GENE VARIANT OFFERS HOPE AGAINST ALZHEIMER’S DISEASE THROUGH INFLAMMATION CONTROL Why in the News? New discovery: A rare gene variant, APOE3-R136S, found to delay Alzheimer’s disease by suppressing brain inflammation and modulating the innate immune response, particularly through the regulation of cyclic GMP-AMP synthesis in the central nervous system. Published study: Findings appear in …

Tag

GLP-1 Drugs: From Weight Loss to Alzheimer’s Care

Rare Gene Variant Fights Alzheimer’s via Inflammation

FREE Career Guidance Program Online | Silver Jubilee Celebration 2026